Ident. | Authors (with country if any) | Title |
---|
000103 (2011) |
Yoichiro Kikuchi [Japon] ; Takao Yasuhara [Japon] ; Takashi Agari [Japon] ; Akihiko Kondo [Japon] ; Satoshi Kuramoto [Japon] ; Masahiro Kameda [Japon] ; Tomohito Kadota [Japon] ; Tanefumi Baba [Japon] ; Naoki Tajiri [Japon] ; Feifei Wang [Japon] ; Judith T. Tayra [Japon] ; Hanbai Liang [Japon] ; Yasuyuki Miyoshi [Japon] ; Cesario V. Borlongan [États-Unis] ; Isao Date [Japon] | Urinary 8‐OHdG elevations in a partial lesion rat model of parkinson's disease correlate with behavioral symptoms and nigrostriatal dopaminergic depletion |
000182 (2011) |
Natalie R. S. Goldberg [États-Unis] ; Tom Hampton [États-Unis] ; Scott Mccue [États-Unis] ; Ajit Kale [États-Unis] ; Charles K. Meshul [États-Unis] | Profiling changes in gait dynamics resulting from progressive 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐induced nigrostriatal lesioning |
000401 (2011) |
Raúl De La Fuente-Fernández [Canada] ; Michael Schulzer [Canada] ; Lisa Kuramoto [Canada] ; Jacquelyn Cragg [Canada] ; Nandhagopal Ramachandiran [Canada] ; Wing L. Au [Canada] ; Edwin Mak [Canada] ; Jess Mckenzie [Canada] ; Siobhan Mccormick [Canada] ; Vesna Sossi [Canada] ; Thomas J. Ruth [Canada] ; Chong S. Lee [Canada] ; Donald B. Calne [Canada] ; A. Jon Stoessl [Canada] | Age‐specific progression of nigrostriatal dysfunction in Parkinson's disease |
000519 (2010) |
Y. K. Kim ; I-Y. Yoon ; J-M. Kim [Corée du Sud] ; S-H. Jeong ; K. W. Kim ; Y-K. Shin ; B. S. Kim ; S. E. Kim | The implication of nigrostriatal dopaminergic degeneration in the pathogenesis of REM sleep behavior disorder |
000784 (2010) |
K. Ishibashi [Japon] ; K. Kanemaru [Japon] ; Y. Saito [Japon] ; S. Murayama [Japon] ; K. Oda [Japon] ; K. Ishiwata [Japon] ; H. Mizusawa [Japon] ; K. Ishii [Japon] | Cerebrospinal fluid metabolite and nigrostriatal dopaminergic function in Parkinson’s disease |
000815 (2010) |
H. C. Yu ; S. F. Feng ; P. L. Chao ; A. M. Y. Lin [Taïwan] | Anti‐inflammatory effects of pioglitazone on iron‐induced oxidative injury in the nigrostriatal dopaminergic system |
000912 (2009) |
David A. Price [États-Unis] ; Alex A. Martinez [États-Unis] ; Alexandre Seillier [États-Unis] ; Wouter Koek [États-Unis] ; Yolanda Acosta [États-Unis] ; Elizabeth Fernandez [États-Unis] ; Randy Strong [États-Unis] ; Beat Lutz [Allemagne] ; Giovanni Marsicano [France] ; James L. Roberts [États-Unis] ; Andrea Giuffrida [États-Unis] | WIN55,212‐2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine mouse model of Parkinson’s disease |
000B15 (2009) |
Nadja Van Camp [Belgique, France] ; Ines Blockx [Belgique] ; Marleen Verhoye [Belgique] ; Cindy Casteels [Belgique] ; Frea Coun [Belgique] ; Alexander Leemans [Royaume-Uni, Pays-Bas] ; Jan Sijbers [Belgique] ; Veerle Baekelandt [Belgique] ; Koen Van Laere [Belgique] ; Annemie Van Der Linden [Belgique] | Diffusion tensor imaging in a rat model of Parkinson's disease after lesioning of the nigrostriatal tract |
000D03 (2008) |
Roberto Ceravolo [Italie] ; Angelo Antonini [Italie] ; Duccio Volterrani [Italie] ; Carlo Rossi [Italie] ; Lorenzo Kiferle [Italie] ; Daniela Frosini [Italie] ; Claudio Lucetti [Italie] ; Ioannis U. Isaias [Italie] ; Riccardo Benti [Italie] ; Luigi Murri [Italie] ; Ubaldo Bonuccelli [Italie] | Predictive value of nigrostriatal dysfunction in isolated tremor: A clinical and SPECT study |
000F27 (2007) |
Fabio Blandini [Italie] ; Giovanna Levandis [Italie] ; Eleonora Bazzini [Italie] ; Giuseppe Nappi [Italie] ; Marie-Therese Armentero [Italie] | Time‐course of nigrostriatal damage, basal ganglia metabolic changes and behavioural alterations following intrastriatal injection of 6‐hydroxydopamine in the rat: new clues from an old model |
000F75 (2007) |
I. Rite [Espagne] ; S. Argüelles [Espagne] ; J. L. Venero [Espagne] ; S. García-Rodriguez [Espagne] ; A. Ayala [Espagne] ; J. Cano [Espagne] ; A. Machado [Espagne] | Proteomic identification of biomarkers in the cerebrospinal fluid in a rat model of nigrostriatal dopaminergic degeneration |
001432 (2005) |
K. Winge [Danemark] ; L. Friberg [Danemark] ; L. Werdelin [Danemark] ; K. K. Nielsen [Danemark] ; H. Stimpel [Danemark] | Relationship between nigrostriatal dopaminergic degeneration, urinary symptoms, and bladder control in Parkinson's disease |
001545 (2005) |
Mahmoud M. Iravani [Royaume-Uni] ; Emilie Syed [Royaume-Uni] ; Michael J. Jackson [Royaume-Uni] ; Louisa C. Johnston [Royaume-Uni] ; Lance A. Smith [Royaume-Uni] ; Peter Jenner [Royaume-Uni] | A modified MPTP treatment regime produces reproducible partial nigrostriatal lesions in common marmosets |
001560 (2004) |
Anthony E. Lang [Canada] ; José A. Obeso [Espagne] | Time to move beyond nigrostriatal dopamine deficiency in Parkinson's disease |
001747 (2003) |
Carl Rosenblad [Danemark] ; Biljana Georgievska [Suède] ; Deniz Kirik [Suède] | Long‐term striatal overexpression of GDNF selectively downregulates tyrosine hydroxylase in the intact nigrostriatal dopamine system |
001808 (2003) |
Raúl De La Fuente-Fernández [Canada] ; Andrew S. Lim [Canada] ; Vesna Sossi [Canada] ; Michael J. Adam [Canada] ; Thomas J. Ruth [Canada] ; Donald B. Calne [Canada] ; A. Jon Stoessl [Canada] ; Chong S. Lee [Canada] | Age and severity of nigrostriatal damage at onset of Parkinson's disease |
001854 (2002) |
Jan Zijlmans [Royaume-Uni, Pays-Bas] ; Jan Booij [Pays-Bas] ; Jaap Valk [Pays-Bas] ; Andrew Lees (neurologue) [Royaume-Uni] ; Martin Horstink [Pays-Bas] | Posttraumatic tremor without parkinsonism in a patient with complete contralateral loss of the nigrostriatal pathway |
001A91 (2001) |
Alexandra Roedter [Allemagne] ; Christian Winkler [Allemagne] ; Madjid Samii [Allemagne] ; Gerhard F. Walter [Allemagne] ; Almuth Brandis [Allemagne] ; Guido Nikkhah [Allemagne] | Comparison of unilateral and bilateral intrastriatal 6‐hydroxydopamine‐induced axon terminal lesions: Evidence for interhemispheric functional coupling of the two nigrostriatal pathways |
001B58 (2000) |
A. Björklund [Suède] ; D. Kirik [Suède] ; C. Rosenblad [Danemark] ; B. Georgievska [Suède] ; C. Lundberg [Suède] ; R. J. Mandel [États-Unis] | Towards a neuroprotective gene therapy for Parkinson’s disease: use of adenovirus, AAV and lentivirus vectors for gene transfer of GDNF to the nigrostriatal system in the rat Parkinson model |
001B84 (2000) |
Ken Nakamura [États-Unis] ; Lisa Won [États-Unis] ; Alfred Heller [États-Unis] ; Un Jung Kang [États-Unis] | Preferential resistance of dopaminergic neurons to glutathione depletion in a reconstituted nigrostriatal system |
001B95 (2000) |
Raúl De La Fuente-Fernández [Canada] ; Asha Kishore [Canada] ; Donald B. Calne [Canada] ; Thomas J. Ruth [Canada] ; A. Jon Stoessl [Canada] | Nigrostriatal dopamine system and motor lateralization |